Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 02/26/21 | 8-K | Current report filing |
|
33 | |
| 02/25/21 | 4 | Lederman Seth |
|
1 | |
| 02/25/21 | 4 | Saenger Bradley |
|
2 | |
| 02/25/21 | 4 | Morris Jessica Edgar |
|
2 | |
| 02/25/21 | 4 | Sullivan Gregory M |
|
2 | |
| 02/19/21 | 8-K | Current report filing |
|
27 | |
| 02/16/21 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
9 | |
| 02/16/21 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 02/12/21 | 5 | Saenger Bradley |
|
2 | |
| 02/11/21 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
9 |
